• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Vitamin D supplementation may aid in preventing migraine

Publication
Article
Contemporary PEDS JournalMarch 2023
Volume 40
Issue 02

In children who are subject to migraine attacks, vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate, results of a study in Saudi Arabia showed.

Vitamin D supplementation may aid in preventing migraine | Image credit: Contemporary Pediatrics

Vitamin D supplementation may aid in preventing migraine | Image credit: Contemporary Pediatrics

In children who are subject to migraine attacks, vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate, results of a study in Saudi Arabia showed.

The 56 children (34 girls and 22 boys), who ranged in age from 5 to 14 years had 2 or more headache attacks each week, were not receiving any migraine preventive therapies other than topiramate, and had not taken vitamin D3 supplements within the past 3 months.

The patients were divided into 2 groups. The intervention group received topiramate tablets (2mg per kg of body weight) in 2 daily divided doses along with 5,000 IU of vitamin D3 for 4 consecutive months. The placebo group received only the topiramate along with a placebo.

Investigators observed a good response to treatment in both groups: 76.13% of patients in the intervention group and 53.5% of those in the placebo group.

However, a comparison of migraine characteristics in the 2 groups at the conclusion of the trial showed that D3 supplementation was more effective than placebo in reducing migraine frequency, severity, duration, and disability.

None of the participants experienced serious adverse reactions, though 4 patients in the intervention group and 6 in the placebo group had mild gastrointestinal complaints.

THOUGHTS FROM DR. FARBER

The question of whether vitamin D supplementation is helpful for conditions besides rickets (eg, for asthma), remains open to question, with numerous contradictory studies (similar to the arguments as to whether coffee or alcohol in moderation is good or bad). Consider this a small victory, unconfirmed for now, for vitamin D proponents.

Reference

Elmala MK, Suliman HA, Al-Shokary A, Ibrahim AO, Kamal NM, Elshorbagy HH, Nasef KA, El Din Fathallah MG. The impact of vitamin D3 supplementation to topiramate therapy on pediatric migraine prophylaxis. J Child Neurol. 2022;37(10-11):833-839. doi:10.1177/08830738221092882.

Related Videos
Tina Tan, MD, FAAP, FIDSA, FPIDS
Related Content
© 2024 MJH Life Sciences

All rights reserved.